Latest Headlines

Latest Headlines

FDA clears Menactra for infants

The FDA has expanded the indication of Sanofi-Aventis' Menactra to include a two-dose schedule for infants and children 9 months through 23 months of age, marking the first time a meningococcal

Breakthrough meningitis vaccine costs only 50 cents a jab

Working with money from the Bill and Melinda Gates Foundation, a team of experts from Seattle-based PATH and the World Health Organization were able to develop a new vaccine for meningitis that costs

Burkina Faso first to receive African meningitis vax

MenAfriVac, a meningitis A vaccine created by the Serum Institute of India, will be dispensed to Burkina Faso's 12 million residents starting Dec. 6. It's the first in the WHO's continent-wide

New vaccine offers hope in fight against pneumonia, meningtis

University of Leicester and Trinity College Dublin researchers have provided promising data in the fight against pneumonia, meningtis and septicaemia--and the discovery could lead to a new

CDC panel backs additional vax doses

Good news for makers of the meningitis vaccine--sort of. A CDC advisory panel recommended a booster shot for teenagers, effectively doubling the number of shots kids would get--and doubling the

Novartis' meningitis B vax passes test

Novartis released promising data from its Phase III trial for 4CMenB, a meningitis B vaccine developed via Novartis' "reverse vaccinology." The study, which involved 3,600 infants from five

Novartis meningitis vax promising in PhIII

Novartis' meningitis B vaccine, 4CMenB, has turned in promising late-stage data with "an acceptable" safety profile. After testing the drug in more than 3,600 infants, Novartis reported that its

Nasal spray vax for meningitis may offer cheap alternative

Scientists at the University of Liverpool have won a hefty new grant to study an experimental nasal spray vaccine that could be used to guard against pneumonia and meningitis. The spray relies on a

New meningitis vax arrives in Africa

A newly approved meningitis vaccine developed by an international consortium that includes Bill Gates and the WHO is being deployed as the first line of defense against the meningitis epidemics that

FDA wants more info on Novartis' Menveo vax

The FDA has asked Novartis for more information on its meningitis vaccine Menveo, which is likely to push back any approval date to late this year or early in 2010. And the manufacturer was quick to